AEBP1 and central nervous system cancer: ACT001 inhibited GSC proliferation and glioma sphere formation through targeting AEBP1/PI3K/AKT signaling and prolonged the survival of animals as a single agent or in combination with SHP099 in an orthotopic GSC xenograft.